1. Home
  2. TCI vs TRDA Comparison

TCI vs TRDA Comparison

Compare TCI & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • TRDA
  • Stock Information
  • Founded
  • TCI 1983
  • TRDA 2016
  • Country
  • TCI United States
  • TRDA United States
  • Employees
  • TCI N/A
  • TRDA N/A
  • Industry
  • TCI Real Estate
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCI Finance
  • TRDA Health Care
  • Exchange
  • TCI Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • TCI 239.1M
  • TRDA 264.5M
  • IPO Year
  • TCI N/A
  • TRDA 2021
  • Fundamental
  • Price
  • TCI $43.27
  • TRDA $6.80
  • Analyst Decision
  • TCI
  • TRDA Strong Buy
  • Analyst Count
  • TCI 0
  • TRDA 3
  • Target Price
  • TCI N/A
  • TRDA $25.67
  • AVG Volume (30 Days)
  • TCI 6.9K
  • TRDA 152.7K
  • Earning Date
  • TCI 08-07-2025
  • TRDA 08-12-2025
  • Dividend Yield
  • TCI N/A
  • TRDA N/A
  • EPS Growth
  • TCI 59.61
  • TRDA N/A
  • EPS
  • TCI 0.92
  • TRDA 0.61
  • Revenue
  • TCI $47,452,000.00
  • TRDA $172,220,000.00
  • Revenue This Year
  • TCI N/A
  • TRDA N/A
  • Revenue Next Year
  • TCI N/A
  • TRDA N/A
  • P/E Ratio
  • TCI $47.13
  • TRDA $11.21
  • Revenue Growth
  • TCI N/A
  • TRDA 5.74
  • 52 Week Low
  • TCI $25.50
  • TRDA $6.48
  • 52 Week High
  • TCI $46.74
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • TCI 55.51
  • TRDA 42.09
  • Support Level
  • TCI $43.26
  • TRDA $6.48
  • Resistance Level
  • TCI $46.23
  • TRDA $7.62
  • Average True Range (ATR)
  • TCI 1.35
  • TRDA 0.37
  • MACD
  • TCI -0.42
  • TRDA 0.00
  • Stochastic Oscillator
  • TCI 15.98
  • TRDA 28.19

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Share on Social Networks: